Pharmacy News

Image description

FDA approves first drug for specific form of Batten disease

BioMarin Pharmaceuticals’ Brineura slows loss of walking ability (ambulation) in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

Image description

Branded thiotepa shipped by Amneal

Tepadina is approved to reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia.

Image description

Generic Vytorin introduced by Teva

Ezetimibe and simvastatin tablets are a prescription medicine that contains two cholesterol-lowering medicines, ezetimibe and simvastatin, which are used along with diet to lower the level of “bad” cholesterol; increase the level of “good” cholesterol; and lower the level of fat in blood.